Best Oncology and Cancer Biology graduate PHD programs - Updated 2022

Keynote Speaker at the Cancer Biology Conference, September 15James Allison, PhD, 2018 Nobel Prize in Physiology or Medicine. James Allison, PhD, chair of Immunology and executive director of the immunotherapy platform at The University of Texas MD Anderson Cancer Center. Caitlin Roake, Cancer Biology and MSTP student in Steven Artandi lab, has been selected for the Stanford BiosciencesExcellence in Teaching Award. This award recognizes a student whose teaching distinguishes them as valued contributors to the School of Medicine and Biosciences community.

Molecular cancer biologists at Duke University seek to understand the complex regulatory mechanisms that govern mammalian cell growth and differentiation, discern how these mechanisms are perturbed in malignant cells, and how our knowledge of these regulatory mechanisms might lead to improved anti-cancer therapy. The Program in Molecular Cancer Biology (MCB) includes faculty from multiple participating departments and centers across Duke University and Duke School of Medicine.

The Cancer Biology, Pharmacology, and Molecular Therapeutics track in the PEMM program provides comprehensive training leading to a Ph.D. or combined M.D.-Ph.D. degrees. The faculty has developed a rigorous course of study and created a supportive environment aimed at providing students with all the tools necessary to compete effectively for the attractive positions in the biomedical sciences. In addition to journal clubs and one elective, course work in Cancer Biology or Current Approaches in Experimental Therapeutics is required.

The Molecular Oncology (MO) Program at Georgetown Lombardi Comprehensive Cancer Center brings together investigators whose mission is to identify and validate molecular pathways critical to the initiation, progression, maintenance and metastases of cancer. MO specifically investigates those aspects of cancer that clearly differentiate cancer from non-cancer cells. The goal is to validate targets, identify the most critical pathways and create novel probes that will lead to a transition for clinical trials with either established or novel agents.

The Ph.D. program in Cancer Biology and Genomics (CBG) focuses on training investigators in strategies to understand the mechanisms of cancer development and progression. This includes cell biological and genomic approaches. The ultimate objective is to translate basic findings into diagnostics, treatments and ultimately cures. The program applies a multidisciplinary approach toward these goals, with the full realization that cancers in different organs represent different diseases.

The Program in Biomedical Sciences at the University of Michigan is an interdisciplinary gateway program that coordinates admissions and the first year of Ph.D. studies for 14 department programs, including Cancer Biology. PIBS offers you the flexibility and convenience of applying to any of our participating programs through one application. We invite you to thoroughly explore Cancer Biology and the other 13 programs before selecting your top preferences when you apply.

CancerHead Neck Cancers, Lung Cancer, Melanoma Skin Cancers, Urologic Cancer. Moores Cancer Center at UC San Diego Health. He has also served on the National Cancer Institute clinical trials planning committee panels. Rangos Medal of Honor for Creativity in Cancer Discovery.

The graduate program in cancer biology offers a course of study and research leading to the Ph.D. degree. Although a master’s degree is offered under special circumstances, students are not admitted for a master’s degree.The graduate program in cancer biology offers a course of study and research leading to the Ph.D. degree. Although a master’s degree is offered under special circumstances, students are not admitted for a master’s degree. The Cancer Biology Graduate Program was established at the McArdle Laboratory for Cancer Research in 1940 as the first graduate program in the United States to offer a degree in basic cancer research. The program now includes more than 50 faculty trainers from multiple departments including Oncology, Medicine, Human Oncology, Cell and Regenerative Biology, Medical Microbiology and Immunology, and others.

The Sheila and David Fuente Graduate Program in Cancer Biology is a university-wide interdisciplinary training program that draws upon clinical and basic sciences from multiple departments and medical school divisions of the University of Miami. The scientific focus is broadly cancer research with an emphasis on fundamental cellular processes, their deregulation in cancer, the identification of novel diagnostics and therapeutic targets. In addition to training in technical aspects, the curriculum places a strong emphasis on scientific reasoning as the most important and portable aspect of PhD training. The cross-disciplinary training includes novel concepts and state-of-the-art techniques of molecular biology, biochemistry, genetics, genomics, proteomics, structural biology, cell biology, pharmacology, and molecular medicine.

The PhD in Cancer Biology program focuses on the disease of cancer, ranging from molecular signaling underlying carcinogenesis to cancer genomics for improving detection, diagnosis and treatment. While the training of cancer researchers has historically been accomplished by individual investigators in the traditional departments, the rapidly expanding knowledge base and complexity of modern genetic and molecular approaches necessitate an approach that is both broader-based, with respect to scientific discipline, and more focused, with respect to this disease entity.